18 results on '"N. Begley"'
Search Results
2. Abstracts from the 3rd International Severe Asthma Forum (ISAF)
- Author
-
M. E. Ketelaar, K. Van De Kant, F. N. Dijk, E. M. M. Klaassen, N. Grotenboer, M. C. Nawijn, E. Dompeling, G. H. Koppelman, Clare Murray, Philip Foden, Lesley Lowe, Hannah Durrington, Adnan Custovic, Angela Simpson, Andrew J. Simpson, Dominick E. Shaw, Ana R. Sousa, Louise J. Fleming, Graham Roberts, Ioannis Pandis, Aruna T. Bansal, Julie Corfield, Scott Wagers, Ratko Djukanovic, Kian Fan Chung, Peter J. Sterk, Jorgen Vestbo, Stephen J. Fowler, S. J. Tebbutt, A. Singh, C. P. Shannon, Y. W. Kim, C. X. Yang, G. M. Gauvreau, J. M. Fitzgerald, L. P. Boulet, P. M. O’Byrne, N. Begley, A. Loudon, D. W. Ray, Selene Baos, Lucía Cremades, David Calzada, Carlos Lahoz, Blanca Cárdaba, Kewal Asosingh, Chris Lauruschkat, Kimberly Queisser, Nicholas Wanner, Kelly Weiss, Weiling Xu, Serpil Erzurum, Milena Sokolowska, Li-Yuan Chen, Yueqin Liu, Asuncion Martinez-Anton, Carolea Logun, Sara Alsaaty, Rosemarie Cuento, Rongman Cai, Junfeng Sun, Oswald Quehenberger, Aaron Armando, Edward Dennis, Stewart Levine, James Shelhamer, Kilyong Choi, Snezhina Lazova, Penka Perenovska, Dimitrinka Miteva, Stamatios Priftis, Guergana Petrova, Vassil Yablanski, Evgeni Vlaev, Hristina Rafailova, Takashi Kumae, L. J. Holmes, J. Yorke, D. M. Ryan, Sasawan Chinratanapisit, Khlongtip Matchimmadamrong, Jitladda Deerojanawong, Wissaroot Karoonboonyanan, Paskorn Sritipsukho, Vania Youroukova, Denitsa Dimitrova, Yanina Slavova, Spaska Lesichkova, Iren Tzocheva, Snezhana Parina, Svetla Angelova, Neli Korsun, Mihai Craiu, Iustina Violeta Stan, Matea Deliu, Tolga Yavuz, Matthew Sperrin, Umit M. Sahiner, Danielle Belgrave, Cansin Sackesen Sackesen, Ömer Kalayci, Petar Velikov, Tsvetelina Velikova, Ekaterina Ivanova-Todorova, Kalina Tumangelova-Yuzeir, Dobroslav Kyurkchiev, Spyridon Megremis, Bede Constantinides, Alexandros Georgios Sotiropoulos, Paraskevi Xepapadaki, David Robertson, Nikolaos Papadopoulos, Maxim Wilkinson, Craig Portsmouth, David Ray, Royston Goodacre, Anna Valerieva, Irina Bobolea, Daiana Guillén Vera, Gabriel Gonzalez-Salazar, Carlos Melero Moreno, Consuelo Fernandez Rodriguez, Natividad De Las Cuevas Moreno, R. Wang, I. Satia, R. Niven, J. A. Smith, T. Southworth, J. Plumb, V. Gupta, J. Pearson, I. Ramis, M. D. Lehner, M. Miralpeix, D. Singh, Imran Satia, Mark Woodhead, Paul O’Byrne, Jaclyn Ann Smith, Cecilia Forss, Peter Cook, Sheila Brown, Freya Svedberg, Katherine Stephenson, Margherita Bertuzzi, Elaine Bignell, Malin Enerbäck, Danen Cunoosamy, Andrew Macdonald, Caini Liu, Liang Zhu, Kiochi Fukuda, Cunjin Zhang, Suidong Ouyang, Xing Chen, Luke Qin, Suguna Rachakonda, Mark Aronica, Jun Qin, Xiaoxia Li, Marie-Chantal Larose, Anne-Sophie Archambault, Véronique Provost, Jamila Chakir, Michel Laviolette, Nicolas Flamand, Nicola Logan, Dominik Ruckerl, Judith E. Allen, Tara E. Sutherland, E. Hamelmann, C. Vogelberg, S. Goldstein, G. E. Azzi, M. Engel, R. Sigmund, S. J. Szefler, Raquel Mesquita, Luis Coentrão, Rui Veiga, José-Artur Paiva, Roberto Roncon-Albuquerque, Wendy Vargas Porras, Ana González Moreno, Jesus Macías Iglesias, Gustavo Córdova Ramos, Yesenia Peña Acevedo, Miguel Angel Tejedor Alonso, Maria Del Mar Moro Moro, Irena Krcmova, Jakub Novosad, Nicola Alexander Hanania, Marc Massanari, Heike Hecker, Eric Kassel, Craig Laforce, Kathy Rickard, Sanne Snelder, Gert-Jan Braunstahl, T. L. Jones, D. Neville, E. R. Heiden, E. Lanning, T. Brown, H. Rupani, K. S. Babu, A. J. Chauhan, M. Y. Eldegeir, A. A. Chapman, M. Ferwana, and M. Caldron
- Subjects
Immunologic diseases. Allergy ,RC581-607 - Published
- 2017
- Full Text
- View/download PDF
3. Evaluating the impacts of patient engagement on a national health research network: results of a case study of the Chronic Pain Network
- Author
-
Laura Tripp, Dawn P. Richards, Jennifer Daly-Cyr, Therese Lane, Delane Linkiewich, Kimberly N. Begley, Norman Buckley, Maria Hudspith, Patricia Poulin, and Julia Abelson
- Subjects
Evaluation ,Patient and public involvement ,Patient engagement ,Medicine ,Medicine (General) ,R5-920 - Abstract
Abstract Background The Chronic Pain Network (CPN) is a pan-Canadian research network focused on innovating and improving the quality and delivery of pain prevention, assessment, management and research for all Canadians. An important focus of the CPN is to work in collaboration with patient partners. Patient partners, researchers and clinicians work together in all aspects of the research network including on funded research projects and in the governance of the Network. Given this focus, the CPN identified the importance of evaluating their patient engagement work to understand its functioning and impact. Methods The objective of this exploratory evaluation case study was to understand the impacts of patient engagement on the CPN. The CPN worked with an external evaluation team which established an arms-length approach to the evaluation. Interviews were conducted with CPN members, including patient partners, leadership, funded researchers and committee co-chairs, at three discrete time points to trace the evolution of the patient engagement program within the Network. Key Network documents were also collected and reviewed. Data were analyzed following each set of interviews using content analysis guided by the principles of constant comparison and qualitative description. A final round of analysis was conducted using the Engage with Impact Toolkit, an impact measurement framework, to identify impacts of engagement. Results Impacts of patient engagement were identified at the individual, network, funded research project and research community levels. These impacts were observed in the following areas: (1) building community; (2) developing knowledge, skills and resources; (3) increasing confidence; (4) influencing priorities and decisions; (5) enabling additional opportunities; (6) promoting culture change; and, (7) coping with experiences of living with chronic pain. Conclusions While not without challenges, the patient engagement efforts of the CPN demonstrates the impact engaging patient partners can have on a national research network and related policy activities. Understanding the approaches to, and impacts of, patient engagement on health research networks can illuminate the value of having patient partners engaged in all aspects of a research network and should serve as encouragement to others who look to take on similar work.
- Published
- 2023
- Full Text
- View/download PDF
4. A rare case of breast neuroendocrine carcinoma
- Author
-
S Kolagatla, H Bhopalwala, F Smith, N Begley, S Eversole, J Piercy, and N Moka
- Subjects
General Medicine - Published
- 2023
- Full Text
- View/download PDF
5. Out of the shadows: Chronic pain in Canadian Armed Forces veterans — Proceedings of a workshop at the 2019 Forum of the Canadian Institute for Military and Veteran Health Research
- Author
-
Alexandra Heber, Eleni G. Hapidou, Daniel Lamoureux, Ramesh Zacharias, Kimberly N. Begley, James M. Thompson, Norm Buckley, Gaurav Gupta, and Markus Besemann
- Subjects
lcsh:R5-920 ,medicine.medical_specialty ,business.industry ,pain clinics ,lcsh:RM1-950 ,education ,Chronic pain ,medicine.disease ,Veterans health ,humanities ,Military personnel ,lcsh:Therapeutics. Pharmacology ,Anesthesiology and Pain Medicine ,Pain Clinics ,Family medicine ,Medicine ,military personnel ,pain ,veterans ,lcsh:Medicine (General) ,business ,chronic pain ,health care economics and organizations ,Article Commentary - Abstract
This commentary summarizes proceedings of a workshop on chronic pain in military personnel and veterans (released personnel) at the Annual Forum of the Canadian Institute for Military and Veteran Health Research in Gatineau and Ottawa on October 22, 2019. The extent and impact of chronic pain among Canadian Armed Forces (CAF) veterans and their families is significant and has been underappreciated, largely due to limited disclosure by serving and veteran military personnel, stemming from a fear of stigmatization. Living with pain is seen as a fact of life in military cultures, something to be endured and not discussed. Though progress is being made in reducing the stigma of mental illness, the discourse on chronic pain remains censored. This workshop's goal was to bring the discussion of chronic pain out of the shadows in the search for ways to help veterans and active service personnel living with chronic pain. Many points of view were brought forward at this first national Canadian multidisciplinary gathering of researchers, veterans with lived experience, clinicians, and policymakers. A CAF member described his lived experience with constant chronic pain. Clinicians described aspects of chronic pain in military personnel and veterans whom they treat in their clinics. Dr. Ramesh Zacharias described the new Chronic Pain Center of Excellence for Canadian Veterans that will be established with funding from Veterans Affairs Canada. Dr. Norman Buckley highlighted collaboration with the existing Chronic Pain Network funded by the Canadian Institute for Health Research. Audience members identified a diverse variety of issues.Ce commentaire résume les actes d’un atelier sur la douleur chronique chez le personnel militaire et les anciens combattants (personnel libéré) tenu dans le cadre du Forum annuel de l’Institut canadien de recherche sur la santé des militaires et des vétérans à Gatineau et Ottawa le 22 octobre 2019. L’étendue et l’effet de la douleur chronique chez les anciens combattants des Forces armées canadiennes (FAC) et leurs familles sont importantes et ont été sous-estimées, en grande partie en raison de la divulgation limitée par le personnel militaire en service et les anciens combattants, découlant de la peur de la stigmatisation. Le fait de vivre avec la douleur est considéré comme faisant partie de la vie dans les cultures militaires, quelque chose qu’il faut endurer et dont il ne faut pas discuter. Bien que des progrès aient été réalisés dans la réduction de la stigmatisation de la maladie mentale, le discours sur la douleur chronique continue d’être censuré. L’objectif de cet atelier était de faire sortir de l’ombre la discussion sur la douleur chronique afin de chercher des moyens d’aider les anciens combattants et le personnel de service actif vivant avec la douleur chronique. De nombreux points de vue ont été exprimés lors de cette première rencontre multidisciplinaire nationale canadienne réunissant des chercheurs, des anciens combattants ayant vécu l’expérience de la douleur chronique, des cliniciens et des décideurs. Un membre des FAC a décrit l’expérience de douleur chronique qu’il a vécue. Les cliniciens ont décrit les aspects de la douleur chronique chez le personnel militaire et les anciens combattants qu’ils traitent dans leurs cliniques. Le Dr Ramesh Zacharias a décrit le nouveau Centre d’excellence sur la douleur chronique pour les vétérans canadiens qui sera établi grâce au financement d’Anciens Combattants Canada. Le Dr Norman Buckley a souligné la collaboration avec le Réseau de douleur chronique existant financé par l’Institut canadien de la recherche en santé. Les membres de l’audience ont relevé divers problèmes.
- Published
- 2020
6. Guidance on authorship with and acknowledgement of patient partners in patient-oriented research
- Author
-
Dawn P. Richards, Therese Lane, Kathleen Eubanks, Jennifer Stinson, Kathryn A. Birnie, Kimberly N. Begley, Delane Linkiewich, and Lesley Singer
- Subjects
Warrant ,Health (social science) ,Academic authorship ,Process (engineering) ,Acknowledgement ,Patient engagement ,lcsh:Medicine ,Patient partner ,03 medical and health sciences ,0302 clinical medicine ,Documentation ,030212 general & internal medicine ,Patient involvement ,Medical education ,lcsh:R5-920 ,030503 health policy & services ,Corporate governance ,lcsh:R ,Authorship ,Patient-oriented research ,General Health Professions ,Commentary ,Publication ,Guidance ,0305 other medical science ,Psychology ,lcsh:Medicine (General) ,Meaning (linguistics) - Abstract
The Strategy for Patient-Oriented Research Chronic Pain Network was founded in 2016 and is a patient-oriented research network funded by the Canadian Institutes of Health Research. The Network incorporates patient partners throughout its governance and operations meaning that patient partners may contribute to research projects in ways that warrant scientific authorship as defined by the International Committee of Medical Journal Editors. The Network did a brief informal review of guidance on patient authorship in 2019, but could not find any practical documentation to guide its members on this topic. Note the term patient partner here refers to a patient (or caregiver or other person with lived experience) who is a partner or collaborator on a research team. This guidance does not address patients as participants in a research study. This guidance has been co-written by a group of researchers and patient partners of the Chronic Pain Network in an effort to address this gap. It is intended for both researchers and patient partner audiences. This guidance is meant to facilitate conversations between researchers and patient partners about authorship and/or acknowledgement regarding research projects on which they collaborate. While the overall principles of academic authorship and acknowledgement remain unchanged, nuances for interpreting these principles through the lens of patient engagement or patient-oriented research is provided. Teams that carry out patient-oriented research projects will require different preparation to empower all team members (researchers and patient partners) to discuss authorship and acknowledgement. To facilitate these conversations, we have included an overview of the scientific publishing process, explanation of some common terms, and sets of considerations are provided for both patient partners and researchers in determining the range of team member contribution from acknowledgement to authorship. Conversations about authorship can be difficult, even for established research teams. This guidance, and the resources discussed within it, are provided with the intention of making these conversations easier and more thoughtful.
- Published
- 2020
- Full Text
- View/download PDF
7. Abstracts from the 3rd International Severe Asthma Forum (ISAF)
- Author
-
Khlongtip Matchimmadamrong, J. Yorke, M. C. Nawijn, David Robertson, Serpil C. Erzurum, Evgeni Vlaev, Matthew Sperrin, Cecilia Forss, Jun Qin, A. A. Chapman, E. M. M. Klaassen, K. S. Babu, Tsvetelina Velikova, Consuelo Fernandez Rodriguez, Natividad De Las Cuevas Moreno, Rui Veiga, Nicola Logan, Clare S. Murray, Dominick E. Shaw, Vandana Gupta, Peter C. Cook, Li-Yuan Chen, Junfeng Sun, Louise Fleming, Sanne M. Snelder, Irina Bobolea, Dave Singh, N. Begley, James Shelhamer, Xing Chen, Kimberly Queisser, Gabriel Gonzalez-Salazar, Dan Neville, Freya Svedberg, Andrew Simpson, Jamila Chakir, C. P. Shannon, L. J. Holmes, Mark Woodhead, Philip Foden, Maria Del Mar Moro Moro, Yueqin Liu, Judith E. Allen, Gail M. Gauvreau, Paskorn Sritipsukho, Gustavo Córdova Ramos, Caini Liu, Miguel Angel Tejedor Alonso, Liang Zhu, Peter J. Sterk, Xiaoxia Li, David W. Ray, Stan Szefler, E. Dompeling, Blanca Cárdaba, Edward Dennis, Daiana Guillén Vera, Rosemarie Cuento, Oswald Quehenberger, Ana González Moreno, Kathy Rickard, Ellie Lanning, Kalina Tumangelova-Yuzeir, Eckard Hamelmann, Bede Constantinides, Tom C. Brown, M. Caldron, G. E. Azzi, Marie-Chantal Larose, Carlos Lahoz, Luis Coentrão, Andrew Macdonald, Penka Perenovska, Michael Engel, F. N. Dijk, Yesenia Peña Acevedo, S. J. Tebbutt, M. E. Ketelaar, I. Satia, Weiling Xu, Nicolas Flamand, Isabel Ramis, José-Artur Paiva, Maxim Wilkinson, Martin D. Lehner, J. M. Fitzgerald, Eric Kassel, Nicholas Wanner, Takashi Kumae, Y. W. Kim, N. Grotenboer, S. Goldstein, Montserrat Miralpeix, Kian Fan Chung, Omer Kalayci, Véronique Provost, Umit Murat Sahiner, Anne-Sophie Archambault, M. Ferwana, Milena Sokolowska, M. Y. Eldegeir, Svetla Angelova, Sasawan Chinratanapisit, David Calzada, Kilyong Choi, Nikolaos G. Papadopoulos, Matea Deliu, Spaska Lesichkova, Roberto Roncon-Albuquerque, Ana R. Sousa, Scott Wagers, Tolga S Yavuz, Vassil Yablanski, Margherita Bertuzzi, D. M. Ryan, Carlos Melero Moreno, Carolea Logun, Christian Vogelberg, Elaine Bignell, Petar Velikov, Ratko Djukanovic, Ralf Sigmund, Anna Valerieva, Spyridon Megremis, Snezhina Lazova, R. Niven, A. Singh, Danen Cunoosamy, Paraskevi Xepapadaki, Craig Laforce, Wendy Vargas Porras, Aruna T. Bansal, Adnan Custovic, Michel Laviolette, Chris Lauruschkat, Jakub Novosad, Katherine Stephenson, Jesus Macías Iglesias, Paul M. O'Byrne, R. Wang, Yanina Slavova, K.D.G. van de Kant, Cunjin Zhang, Ekaterina Ivanova-Todorova, Wissaroot Karoonboonyanan, Iren Tzocheva, Tara E. Sutherland, Jørgen Vestbo, Selene Baos, Mihai Craiu, Andrew S. I. Loudon, Guergana Petrova, Aaron Armando, Danielle Belgrave, Dimitrinka Miteva, Suguna Rachakonda, Lucía Cremades, Craig Portsmouth, Royston Goodacre, Marc Massanari, Sheila Brown, C. X. Yang, Irena Krčmová, Louis P. Boulet, Suidong Ouyang, Snezhana Parina, Thomas Southworth, Vania Youroukova, Sara Alsaaty, Anoop Chauhan, P. M. O’Byrne, Emily Heiden, Mark A. Aronica, Hristina Rafailova, J. Pearson, Kelly Weiss, J. A. Smith, Imran Satia, Angela Simpson, Dominik Rückerl, Dobroslav Kyurkchiev, Jitladda Deerojanawong, Asuncion Martinez-Anton, Kiochi Fukuda, Graham Roberts, Neli Korsun, Jaclyn A. Smith, Kewal Asosingh, Lesley Lowe, Gerard H. Koppelman, Nicola A. Hanania, Stewart Levine, Raquel Mesquita, Denitsa Dimitrova, Stamatios Priftis, Heike Hecker, Hannah J. Durrington, Ioannis Pandis, Julie Corfield, Hitasha Rupani, D. W. Ray, Iustina Violeta Stan, Thomas Jones, Gert-Jan Braunstahl, Alexandros Georgios Sotiropoulos, Rongman Cai, Luke Qin, Stephen J. Fowler, Malin Enerbäck, Jonathan Plumb, Cansin Sackesen, and Çocuk Sağlığı ve Hastalıkları
- Subjects
Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Allergy ,business.industry ,Severe asthma ,Immunology ,RC581-607 ,medicine.disease ,Meeting Abstracts ,medicine ,Immunology and Allergy ,Immunologic diseases. Allergy ,Intensive care medicine ,business - Published
- 2017
- Full Text
- View/download PDF
8. Circadian clock function does not require the histone methyltransferase MLL3.
- Author
-
Baxter M, Poolman T, Cunningham P, Hunter L, Voronkov M, Kitchen GB, Goosey L, Begley N, Kay D, Hespe A, Maidstone R, Loudon ASI, and Ray DW
- Subjects
- Animals, Circadian Rhythm, Histone Methyltransferases genetics, Histone Methyltransferases metabolism, Histone-Lysine N-Methyltransferase metabolism, Methylation, Mice, Protein Processing, Post-Translational, Circadian Clocks genetics
- Abstract
The circadian clock controls the physiological function of tissues through the regulation of thousands of genes in a cell-type-specific manner. The core cellular circadian clock is a transcription-translation negative feedback loop, which can recruit epigenetic regulators to facilitate temporal control of gene expression. Histone methyltransferase, mixed lineage leukemia gene 3 (MLL3) was reported to be required for the maintenance of circadian oscillations in cultured cells. Here, we test the role of MLL3 in circadian organization in whole animals. Using mice expressing catalytically inactive MLL3, we show that MLL3 methyltransferase activity is in fact not required for circadian oscillations in vitro in a range of tissues, nor for the maintenance of circadian behavioral rhythms in vivo. In contrast to a previous report, loss of MLL3-dependent methylation did not affect the global levels of H3K4 methylation in liver, indicating substantial compensation from other methyltransferases. Furthermore, we found little evidence of genomic repositioning of H3K4me3 marks. We did, however, observe repositioning of H3K4me1 from intronic regions to intergenic regions and gene promoters; however, there were no changes in H3K4me1 mark abundance around core circadian clock genes. Output functions of the circadian clock, such as control of inflammation, were largely intact in MLL3-methyltransferase-deficient mice, although some gene-specific changes were observed, with sexually dimorphic loss of circadian regulation of specific cytokines. Taken together, these observations indicate that MLL3-directed histone methylation is not essential for core circadian clock function; however, it may influence the inflammatory response., (© 2022 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology.)
- Published
- 2022
- Full Text
- View/download PDF
9. Quantification of protein abundance and interaction defines a mechanism for operation of the circadian clock.
- Author
-
Koch AA, Bagnall JS, Smyllie NJ, Begley N, Adamson AD, Fribourgh JL, Spiller DG, Meng QJ, Partch CL, Strimmer K, House TA, Hastings MH, and Loudon ASI
- Subjects
- ARNTL Transcription Factors genetics, ARNTL Transcription Factors metabolism, Animals, CLOCK Proteins genetics, CLOCK Proteins metabolism, Circadian Rhythm genetics, Mammals metabolism, Circadian Clocks genetics
- Abstract
The mammalian circadian clock exerts control of daily gene expression through cycles of DNA binding. Here, we develop a quantitative model of how a finite pool of BMAL1 protein can regulate thousands of target sites over daily time scales. We used quantitative imaging to track dynamic changes in endogenous labelled proteins across peripheral tissues and the SCN. We determine the contribution of multiple rhythmic processes coordinating BMAL1 DNA binding, including cycling molecular abundance, binding affinities, and repression. We find nuclear BMAL1 concentration determines corresponding CLOCK through heterodimerisation and define a DNA residence time of this complex. Repression of CLOCK:BMAL1 is achieved through rhythmic changes to BMAL1:CRY1 association and high-affinity interactions between PER2:CRY1 which mediates CLOCK:BMAL1 displacement from DNA. Finally, stochastic modelling reveals a dual role for PER:CRY complexes in which increasing concentrations of PER2:CRY1 promotes removal of BMAL1:CLOCK from genes consequently enhancing ability to move to new target sites., Competing Interests: AK, JB, NS, NB, AA, JF, DS, QM, CP, KS, TH, MH, AL No competing interests declared, (© 2022, Koch et al.)
- Published
- 2022
- Full Text
- View/download PDF
10. The histone methyltransferase Ezh2 restrains macrophage inflammatory responses.
- Author
-
Kitchen GB, Hopwood T, Gali Ramamoorthy T, Downton P, Begley N, Hussell T, Dockrell DH, Gibbs JE, Ray DW, and Loudon ASI
- Subjects
- Animals, Cells, Cultured, Macrophages cytology, Mice, Inbred C57BL, Neutrophils cytology, Mice, Enhancer of Zeste Homolog 2 Protein immunology, Inflammation immunology, Macrophages immunology, Neutrophils immunology
- Abstract
Robust inflammatory responses are critical to survival following respiratory infection, with current attention focused on the clinical consequences of the Coronavirus pandemic. Epigenetic factors are increasingly recognized as important determinants of immune responses, and EZH2 is a prominent target due to the availability of highly specific and efficacious antagonists. However, very little is known about the role of EZH2 in the myeloid lineage. Here, we show EZH2 acts in macrophages to limit inflammatory responses to activation, and in neutrophils for chemotaxis. Selective genetic deletion in macrophages results in a remarkable gain in protection from infection with the prevalent lung pathogen, pneumococcus. In contrast, neutrophils lacking EZH2 showed impaired mobility in response to chemotactic signals, and resulted in increased susceptibility to pneumococcus. In summary, EZH2 shows complex, and divergent roles in different myeloid lineages, likely contributing to the earlier conflicting reports. Compounds targeting EZH2 are likely to impair mucosal immunity; however, they may prove useful for conditions driven by pulmonary neutrophil influx, such as adult respiratory distress syndrome., (© 2021 The Authors. The FASEB Journal published by Wiley Periodicals LLC on behalf of Federation of American Societies for Experimental Biology.)
- Published
- 2021
- Full Text
- View/download PDF
11. Circadian asthma airway responses are gated by REV-ERBα.
- Author
-
Durrington HJ, Krakowiak K, Meijer P, Begley N, Maidstone R, Goosey L, Gibbs JE, Blaikley JF, Gregory LG, Lloyd CM, Loudon ASI, and Ray DW
- Subjects
- Animals, Circadian Rhythm, Inflammation, Mice, Nuclear Receptor Subfamily 1, Group D, Member 1 genetics, Asthma, Circadian Clocks
- Abstract
Background: The circadian clock powerfully regulates inflammation and the clock protein REV-ERBα is known to play a key role as a repressor of the inflammatory response. Asthma is an inflammatory disease of the airways with a strong time of day rhythm. Airway hyper-responsiveness (AHR) is a dominant feature of asthma; however, it is not known if this is under clock control., Objectives: To determine if allergy-mediated AHR is gated by the clock protein REV-ERBα., Methods: After exposure to the intra-nasal house dust mite (HDM) allergen challenge model at either dawn or dusk, AHR to methacholine was measured invasively in mice., Main Results: Wild-type (WT) mice show markedly different time of day AHR responses (maximal at dusk/start of the active phase), both in vivo and ex vivo , in precision cut lung slices. Time of day effects on AHR were abolished in mice lacking the clock gene Rev-erb α, indicating that such effects on asthma response are likely to be mediated via the circadian clock. We suggest that muscarinic receptors one ( Chrm 1 ) and three ( Chrm 3 ) may play a role in this pathway., Conclusions: We identify a novel circuit regulating a core process in asthma, potentially involving circadian control of muscarinic receptor expression, in a REV-ERBα dependent fashion., Clinical Implication: These insights suggest the importance of considering the timing of drug administration in clinic trials and in clinical practice (chronotherapy)., Competing Interests: Conflict of interest: K. Krakowiak has nothing to disclose. Conflict of interest: P. Meijer has nothing to disclose. Conflict of interest: N. Begley has nothing to disclose. Conflict of interest: R. Maidstone has nothing to disclose. Conflict of interest: L. Goosey has nothing to disclose. Conflict of interest: J.E. Gibbs has nothing to disclose. Conflict of interest: J.F. Blaikley has nothing to disclose. Conflict of interest: L.G. Gregory has nothing to disclose. Conflict of interest: C.M. Lloyd has nothing to disclose. Conflict of interest: A.S.I. Loudon has nothing to disclose. Conflict of interest: D.W. Ray has nothing to disclose. Conflict of interest: H.J. Durrington has nothing to disclose., (Copyright ©ERS 2020.)
- Published
- 2020
- Full Text
- View/download PDF
12. The clock gene Bmal1 inhibits macrophage motility, phagocytosis, and impairs defense against pneumonia.
- Author
-
Kitchen GB, Cunningham PS, Poolman TM, Iqbal M, Maidstone R, Baxter M, Bagnall J, Begley N, Saer B, Hussell T, Matthews LC, Dockrell DH, Durrington HJ, Gibbs JE, Blaikley JF, Loudon AS, and Ray DW
- Subjects
- Actins metabolism, Animals, Circadian Clocks genetics, Circadian Clocks physiology, Cytoskeleton, Disease Models, Animal, Female, Mice, Mice, Inbred C57BL, Mice, Knockout, Streptococcus pneumoniae pathogenicity, rhoA GTP-Binding Protein metabolism, ARNTL Transcription Factors antagonists & inhibitors, ARNTL Transcription Factors genetics, Cell Movement drug effects, Disease Resistance genetics, Macrophages drug effects, Phagocytosis drug effects, Pneumonia, Pneumococcal metabolism
- Abstract
The circadian clock regulates many aspects of immunity. Bacterial infections are affected by time of day, but the mechanisms involved remain undefined. Here we show that loss of the core clock protein BMAL1 in macrophages confers protection against pneumococcal pneumonia. Infected mice show both reduced weight loss and lower bacterial burden in circulating blood. In vivo studies of macrophage phagocytosis reveal increased bacterial ingestion following Bmal1 deletion, which was also seen in vitro. BMAL1
-/- macrophages exhibited marked differences in actin cytoskeletal organization, a phosphoproteome enriched for cytoskeletal changes, with reduced phosphocofilin and increased active RhoA. Further analysis of the BMAL1-/- macrophages identified altered cell morphology and increased motility. Mechanistically, BMAL1 regulated a network of cell movement genes, 148 of which were within 100 kb of high-confidence BMAL1 binding sites. Links to RhoA function were identified, with 29 genes impacting RhoA expression or activation. RhoA inhibition restored the phagocytic phenotype to that seen in control macrophages. In summary, we identify a surprising gain of antibacterial function due to loss of BMAL1 in macrophages, associated with a RhoA-dependent cytoskeletal change, an increase in cell motility, and gain of phagocytic function., Competing Interests: The authors declare no competing interest., (Copyright © 2020 the Author(s). Published by PNAS.)- Published
- 2020
- Full Text
- View/download PDF
13. The circadian clock protein REVERBα inhibits pulmonary fibrosis development.
- Author
-
Cunningham PS, Meijer P, Nazgiewicz A, Anderson SG, Borthwick LA, Bagnall J, Kitchen GB, Lodyga M, Begley N, Venkateswaran RV, Shah R, Mercer PF, Durrington HJ, Henderson NC, Piper-Hanley K, Fisher AJ, Chambers RC, Bechtold DA, Gibbs JE, Loudon AS, Rutter MK, Hinz B, Ray DW, and Blaikley JF
- Subjects
- Animals, Bleomycin adverse effects, CLOCK Proteins genetics, CLOCK Proteins therapeutic use, Gene Expression Regulation, Gene Knockdown Techniques, Humans, Idiopathic Pulmonary Fibrosis, Integrins, Lung pathology, Male, Mesenchymal Stem Cells, Mice, Mice, Knockout, Myofibroblasts drug effects, Myofibroblasts metabolism, Pulmonary Fibrosis chemically induced, Pulmonary Fibrosis pathology, TATA Box Binding Protein-Like Proteins metabolism, Transcriptome, CLOCK Proteins antagonists & inhibitors, Circadian Clocks physiology, Fibroblasts drug effects, Pulmonary Fibrosis drug therapy
- Abstract
Pulmonary inflammatory responses lie under circadian control; however, the importance of circadian mechanisms in the underlying fibrotic phenotype is not understood. Here, we identify a striking change to these mechanisms resulting in a gain of amplitude and lack of synchrony within pulmonary fibrotic tissue. These changes result from an infiltration of mesenchymal cells, an important cell type in the pathogenesis of pulmonary fibrosis. Mutation of the core clock protein REVERBα in these cells exacerbated the development of bleomycin-induced fibrosis, whereas mutation of REVERBα in club or myeloid cells had no effect on the bleomycin phenotype. Knockdown of REVERBα revealed regulation of the little-understood transcription factor TBPL1. Both REVERBα and TBPL1 altered integrinβ1 focal-adhesion formation, resulting in increased myofibroblast activation. The translational importance of our findings was established through analysis of 2 human cohorts. In the UK Biobank, circadian strain markers (sleep length, chronotype, and shift work) are associated with pulmonary fibrosis, making them risk factors. In a separate cohort, REVERBα expression was increased in human idiopathic pulmonary fibrosis (IPF) lung tissue. Pharmacological targeting of REVERBα inhibited myofibroblast activation in IPF fibroblasts and collagen secretion in organotypic cultures from IPF patients, thus suggesting that targeting of REVERBα could be a viable therapeutic approach., Competing Interests: The authors declare no competing interest., (Copyright © 2020 the Author(s). Published by PNAS.)
- Published
- 2020
- Full Text
- View/download PDF
14. Genome-wide effect of pulmonary airway epithelial cell-specific Bmal1 deletion.
- Author
-
Zhang Z, Hunter L, Wu G, Maidstone R, Mizoro Y, Vonslow R, Fife M, Hopwood T, Begley N, Saer B, Wang P, Cunningham P, Baxter M, Durrington H, Blaikley JF, Hussell T, Rattray M, Hogenesch JB, Gibbs J, Ray DW, and Loudon ASI
- Subjects
- Alveolar Epithelial Cells microbiology, Animals, Cells, Cultured, Circadian Clocks, Female, Gene Deletion, Humans, Lipid Metabolism, Male, Mice, Mice, Inbred C57BL, Orthomyxoviridae Infections genetics, Orthomyxoviridae Infections immunology, Xenobiotics metabolism, ARNTL Transcription Factors genetics, Alveolar Epithelial Cells metabolism, Transcriptome
- Abstract
Pulmonary airway epithelial cells (AECs) form a critical interface between host and environment. We investigated the role of the circadian clock using mice bearing targeted deletion of the circadian gene brain and muscle ARNT-like 1 ( Bmal1 ) in AECs. Pulmonary neutrophil infiltration, biomechanical function, and responses to influenza infection were all disrupted. A circadian time-series RNA sequencing study of laser-captured AECs revealed widespread disruption in genes of the core circadian clock and output pathways regulating cell metabolism (lipids and xenobiotics), extracellular matrix, and chemokine signaling, but strikingly also the gain of a novel rhythmic transcriptome in Bmal1 -targeted cells. Many of the rhythmic components were replicated in primary AECs cultured in air-liquid interface, indicating significant cell autonomy for control of pulmonary circadian physiology. Finally, we found that metabolic cues dictate phasing of the pulmonary clock and circadian responses to immunologic challenges. Thus, the local circadian clock in AECs is vital in lung health by coordinating major cell processes such as metabolism and immunity.-Zhang, Z. Hunter, L., Wu, G., Maidstone, R., Mizoro, Y., Vonslow, R., Fife, M., Hopwood, T., Begley, N., Saer, B., Wang, P., Cunningham, P., Baxter, M., Durrington, H., Blaikley, J. F., Hussell, T., Rattray, M., Hogenesch, J. B., Gibbs, J., Ray, D. W., Loudon, A. S. I. Genome-wide effect of pulmonary airway epithelial cell-specific Bmal1 deletion.
- Published
- 2019
- Full Text
- View/download PDF
15. Circadian variation in pulmonary inflammatory responses is independent of rhythmic glucocorticoid signaling in airway epithelial cells.
- Author
-
Ince LM, Zhang Z, Beesley S, Vonslow RM, Saer BR, Matthews LC, Begley N, Gibbs JE, Ray DW, and Loudon ASI
- Subjects
- Animals, Cells, Cultured, Chemokine CXCL5 metabolism, Circadian Rhythm drug effects, Epithelial Cells drug effects, Epithelial Cells metabolism, Epithelial Cells pathology, Glucocorticoids pharmacology, Lipopolysaccharides pharmacology, Macrophages, Peritoneal drug effects, Macrophages, Peritoneal metabolism, Macrophages, Peritoneal pathology, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Neutrophil Infiltration, Neutrophils drug effects, Neutrophils metabolism, Neutrophils pathology, Pneumonia drug therapy, Pneumonia metabolism, Pneumonia pathology, Respiratory System drug effects, Respiratory System metabolism, Respiratory System pathology, Signal Transduction, Circadian Rhythm immunology, Epithelial Cells immunology, Macrophages, Peritoneal immunology, Neutrophils immunology, Pneumonia immunology, Receptors, Glucocorticoid physiology, Respiratory System immunology
- Abstract
The circadian clock is a critical regulator of immune function. We recently highlighted a role for the circadian clock in a mouse model of pulmonary inflammation. The epithelial clock protein Bmal1 was required to regulate neutrophil recruitment in response to inflammatory challenge. Bmal1 regulated glucocorticoid receptor (GR) recruitment to the neutrophil chemokine, CXC chemokine ligand 5 (CXCL5), providing a candidate mechanism. We now show that clock control of pulmonary neutrophilia persists without rhythmic glucocorticoid availability. Epithelial GR-null mice had elevated expression of proinflammatory chemokines in the lung under homeostatic conditions. However, deletion of GR in the bronchial epithelium blocked rhythmic CXCL5 production, identifying GR as required to confer circadian control to CXCL5. Surprisingly, rhythmic pulmonary neutrophilia persisted, despite nonrhythmic CXCL5 responses, indicating additional circadian control mechanisms. Deletion of GR in myeloid cells alone did not prevent circadian variation in pulmonary neutrophilia and showed reduced neutrophilic inflammation in response to dexamethasone treatment. These new data show GR is required to confer circadian control to some inflammatory chemokines, but that this alone is insufficient to prevent circadian control of neutrophilic inflammation in response to inhaled LPS, with additional control mechanisms arising in the myeloid cell lineage.-Ince, L. M., Zhang, Z., Beesley, S., Vonslow, R. M., Saer, B. R., Matthews, L. C., Begley, N., Gibbs, J. E., Ray, D. W., Loudon, A. S. I. Circadian variation in pulmonary inflammatory responses is independent of rhythmic glucocorticoid signaling in airway epithelial cells.
- Published
- 2019
- Full Text
- View/download PDF
16. REVERBa couples the circadian clock to hepatic glucocorticoid action.
- Author
-
Caratti G, Iqbal M, Hunter L, Kim D, Wang P, Vonslow RM, Begley N, Tetley AJ, Woodburn JL, Pariollaud M, Maidstone R, Donaldson IJ, Zhang Z, Ince LM, Kitchen G, Baxter M, Poolman TM, Daniels DA, Stirling DR, Brocker C, Gonzalez F, Loudon AS, Bechtold DA, Rattray M, Matthews LC, and Ray DW
- Subjects
- Animals, Chromatin genetics, Chromatin pathology, Circadian Clocks genetics, Energy Metabolism drug effects, Energy Metabolism genetics, Fatty Liver chemically induced, Fatty Liver genetics, Fatty Liver pathology, Glucocorticoids pharmacology, HEK293 Cells, Humans, Liver pathology, Mice, Mice, Knockout, Nuclear Receptor Subfamily 1, Group D, Member 1 genetics, Receptors, Glucocorticoid genetics, Receptors, Glucocorticoid metabolism, Chromatin metabolism, Circadian Clocks drug effects, Fatty Liver metabolism, Glucocorticoids adverse effects, Liver metabolism, Nuclear Receptor Subfamily 1, Group D, Member 1 metabolism
- Abstract
The glucocorticoid receptor (GR) is a major drug target in inflammatory disease. However, chronic glucocorticoid (GC) treatment leads to disordered energy metabolism, including increased weight gain, adiposity, and hepatosteatosis - all programs modulated by the circadian clock. We demonstrated that while antiinflammatory GC actions were maintained irrespective of dosing time, the liver was significantly more GC sensitive during the day. Temporal segregation of GC action was underpinned by a physical interaction of GR with the circadian transcription factor REVERBa and co-binding with liver-specific hepatocyte nuclear transcription factors (HNFs) on chromatin. REVERBa promoted efficient GR recruitment to chromatin during the day, acting in part by maintaining histone acetylation, with REVERBa-dependent GC responses providing segregation of carbohydrate and lipid metabolism. Importantly, deletion of Reverba inverted circadian liver GC sensitivity and protected mice from hepatosteatosis induced by chronic GC administration. Our results reveal a mechanism by which the circadian clock acts through REVERBa in liver on elements bound by HNF4A/HNF6 to direct GR action on energy metabolism.
- Published
- 2018
- Full Text
- View/download PDF
17. Circadian clock component REV-ERBα controls homeostatic regulation of pulmonary inflammation.
- Author
-
Pariollaud M, Gibbs JE, Hopwood TW, Brown S, Begley N, Vonslow R, Poolman T, Guo B, Saer B, Jones DH, Tellam JP, Bresciani S, Tomkinson NC, Wojno-Picon J, Cooper AW, Daniels DA, Trump RP, Grant D, Zuercher W, Willson TM, MacDonald AS, Bolognese B, Podolin PL, Sanchez Y, Loudon AS, and Ray DW
- Subjects
- Animals, Circadian Clocks genetics, Circadian Rhythm genetics, Homeostasis genetics, Mice, Mice, Transgenic, Nuclear Receptor Subfamily 1, Group D, Member 1 genetics, Pneumonia genetics, Pneumonia pathology, Proteolysis, Sumoylation genetics, Sumoylation immunology, Circadian Clocks immunology, Circadian Rhythm immunology, Homeostasis immunology, Immunity, Innate, Nuclear Receptor Subfamily 1, Group D, Member 1 immunology, Pneumonia immunology
- Abstract
Recent studies reveal that airway epithelial cells are critical pulmonary circadian pacemaker cells, mediating rhythmic inflammatory responses. Using mouse models, we now identify the rhythmic circadian repressor REV-ERBα as essential to the mechanism coupling the pulmonary clock to innate immunity, involving both myeloid and bronchial epithelial cells in temporal gating and determining amplitude of response to inhaled endotoxin. Dual mutation of REV-ERBα and its paralog REV-ERBβ in bronchial epithelia further augmented inflammatory responses and chemokine activation, but also initiated a basal inflammatory state, revealing a critical homeostatic role for REV-ERB proteins in the suppression of the endogenous proinflammatory mechanism in unchallenged cells. However, REV-ERBα plays the dominant role, as deletion of REV-ERBβ alone had no impact on inflammatory responses. In turn, inflammatory challenges cause striking changes in stability and degradation of REV-ERBα protein, driven by SUMOylation and ubiquitination. We developed a novel selective oxazole-based inverse agonist of REV-ERB, which protects REV-ERBα protein from degradation, and used this to reveal how proinflammatory cytokines trigger rapid degradation of REV-ERBα in the elaboration of an inflammatory response. Thus, dynamic changes in stability of REV-ERBα protein couple the core clock to innate immunity.
- Published
- 2018
- Full Text
- View/download PDF
18. The circadian regulator BMAL1 programmes responses to parasitic worm infection via a dendritic cell clock.
- Author
-
Hopwood TW, Hall S, Begley N, Forman R, Brown S, Vonslow R, Saer B, Little MC, Murphy EA, Hurst RJ, Ray DW, MacDonald AS, Brass A, Bechtold DA, Gibbs JE, Loudon AS, and Else KJ
- Subjects
- Animals, Cells, Cultured, Dendritic Cells parasitology, Lymph Nodes parasitology, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, T-Lymphocytes immunology, T-Lymphocytes parasitology, Th2 Cells parasitology, Trichuriasis parasitology, ARNTL Transcription Factors physiology, Circadian Rhythm, Dendritic Cells immunology, Lymph Nodes immunology, Th2 Cells immunology, Trichuriasis immunology, Trichuris pathogenicity
- Abstract
Resistance to the intestinal parasitic helminth Trichuris muris requires T-helper 2 (T
H 2) cellular and associated IgG1 responses, with expulsion typically taking up to 4 weeks in mice. Here, we show that the time-of-day of the initial infection affects efficiency of worm expulsion, with strong TH 2 bias and early expulsion in morning-infected mice. Conversely, mice infected at the start of the night show delayed resistance to infection, and this is associated with feeding-driven metabolic cues, such that feeding restriction to the day-time in normally nocturnal-feeding mice disrupts parasitic expulsion kinetics. We deleted the circadian regulator BMAL1 in antigen-presenting dendritic cells (DCs) in vivo and found a loss of time-of-day dependency of helminth expulsion. RNAseq analyses revealed that IL-12 responses to worm antigen by circadian-synchronised DCs were dependent on BMAL1. Therefore, we find that circadian machinery in DCs contributes to the TH 1/TH 2 balance, and that environmental, or genetic perturbation of the DC clock results in altered parasite expulsion kinetics.- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.